1 / 8

ROS/NO/O2 1a. Introduction: Background

ROS/NO/O2 1a. Introduction: Background. ENDOTHELIAL FUNCTION OF SUBDERMAL MICROVESSELS, PLASMA ADMA AND ROS MARKERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 1 OR EARLY ESSENTIAL HYPERTENSION. Dan Wang, M.D., Ph.D. Christopher Wilcox, M.D., Ph.D. Sven Strangaard , Ph.D.

karik
Download Presentation

ROS/NO/O2 1a. Introduction: Background

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ROS/NO/O21a. Introduction: Background

  2. ENDOTHELIAL FUNCTION OF SUBDERMAL MICROVESSELS, PLASMA ADMA AND ROS MARKERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 1 OR EARLY ESSENTIAL HYPERTENSION • Dan Wang, M.D., Ph.D. • Christopher Wilcox, M.D., Ph.D. • Sven Strangaard, Ph.D. • ShakilAslam, M.D.

  3. CONCLUSIONS • Humans with essential hypertension or CKD-1 have: • reduced microvascular EDRF and NOS • increased circulating ADMA • oxidative stress

More Related